Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  INSULIN PUMPS (EXTERNAL)
A Global Strategic Business Report

This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 18 companies including many key and niche players worldwide such as Animas Corporation, Debiotech S.A., Disetronic Medical Systems AG, Insulet Corporation, Matria Healthcare, Inc., Medtronic Diabetes, Nilimedix Ltd, Nipro Diabetes Systems, Smiths Medical MD, Inc., Sooil Development Co. Ltd., and Starbridge Systems Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-1511  PAGES:    126
PRICE:    $3950  DATE:       May 2008
COMPANIES:  18  MARKET DATA TABLES:   42
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  INSULIN PUMPS (EXTERNAL) (Complete Report) Pages : 126   | $3950
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS3$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
II. EXECUTIVE SUMMARY31$2250
  1. Industry Overview.....II-14 $400  
   Current and Future Analysis.....II-1
Competitive Scenario.....II-1
Tough Ground for New Entrants.....II-1
1$100
   Major Growth Drivers.....II-2
Developments in Insulin Delivering Technologies.....II-2
ICR: A Key Factor to Success.....II-2
1$100
   Emergence of Combination Products.....II-3
Expiry of Warranty Provides New Opportunities.....II-3
Customer Satisfaction.....II-3
Issues and Trends.....II-3
Debate On Superiority of Pump Therapy Over MDI Continues .....II-3
Complicated Software Poses a Threat.....II-3
Lack of Awareness Limits Intensive Insulin Therapy Practice.....II-3
1$100
   Teenagers Outdo Adults in Controlling Diabetes.....II-4
1$100
  2. Diabetes & Insulin – An Abstract.....II-53 $500  
   Diabetes .....II-5
A Fatal Disease.....II-5
Table 1: Leading Countries Worldwide in Terms of Diabetes Population (includes corresponding Graph/Chart).....II-5
Types of Diabetes.....II-5
Long Term Complications of Diabetes.....II-5
1$300
   Testing Sugar Levels: Easy and Accurate.....II-6
Key Drug Classes of Diabetes.....II-6
Insulin.....II-6
Pancreas: The Main Source of Insulin in Human Body.....II-6
Types of Insulin.....II-6
Insulin Delivery Systems.....II-6
a. Syringes.....II-6
1$100
   b. Insulin Pens.....II-7
c. Jet Injectors.....II-7
d. Tablets.....II-7
e. External Insulin Pumps.....II-7
Insulin Delivery Technologies.....II-7
1$100
  3. Product Overview.....II-85 $500  
   An Introduction to Insulin Pumps.....II-8
Insulin Pump – A Replica of Pancreas.....II-8
Advantages.....II-8
More Accurate and Consistent.....II-8
Enhances Blood Sugar Control in Pediatric Patients.....II-8
A Peek into Past.....II-8
1$100
   Components of Insulin Pump.....II-9
How Does an Insulin Pump Work?.....II-9
Insulin Pump Delivery Rates.....II-9
1$100
   Guidelines for Insulin Pump Usage.....II-101$100
   Risks Involved in the Usage of Insulin Pumps.....II-11
Lantus: A Threat to Insulin Pump Manufacturers.....II-11
1$100
   Training: A Crucial Aspect in Insulin Pump Therapy.....II-12
Centers for Medicare & Medicaid Services (CMS): Funding Organizations.....II-12
Implantable Insulin Pumps: Emerging Technology in Insulin Pump Market.....II-12
1$100
  4. Product Innovations/Introductions.....II-135 $500  
   ROCHE Launches Accu-Chek Spirit.....II-13
Smith Medical Launches Cozmo in China.....II-13
Industrial Scholar Devises Wristwatch Insulin Pump.....II-13
Medtronic Unveils Arabic Language Insulin Pump.....II-13
Medtronic Launches New Diabetes Monitoring System.....II-13
1$100
   Debiotech Unveils Miniaturized Insulin Nanopump™.....II-14
Roche Diagnostics Introduces New Insulin Pump System.....II-14
Medtronic Releases New Diabetes Device.....II-14
SpectRx Unveils SimpleChoice Infusion Sets.....II-14
Nipro Diabetes Unveils Amigo ® Insulin Pump.....II-14
1$100
   SpectRx Introduces New Series of Insulin Pumps.....II-15
New OmniPod Insulin Management System from Insulet.....II-15
New1250 Insulin Pumps from Animas.....II-15
Smiths Medical Launches Insulin Pumps in Germany.....II-15
Becton, Dickinson Unveils the First Intelligent Pump.....II-15
1$100
   Medtronic Rolls Out New Pump Systems.....II-16
Accu-Science Launches New Insulin Pumps in Ireland.....II-16
New Insulin Pump Infusion Sets from SpectRx.....II-16
Roche Expands Accu-Chek Product Line.....II-16
Cozmo® Insulin Pump Technology from Smiths.....II-16
1$100
   Medtronic Unveils Paradigm 512 and 712.....II-17
SpectRx Launches Disposable Infusion Set.....II-17
1$100
  5. Recent Industry Activity.....II-189 $600  
   Animas Partners with DexCom.....II-18
Insulet Inks Agreement with DexCom.....II-18
Medtronic Partners with LifeScan.....II-18
Phluid Corporation Inks Agreement with Syprosoft.....II-18
Insulet Partners with Flextronics.....II-18
Medco Absorbs PolyMedica.....II-18
1$100
   Debiotech Allies with STMicroelectronics.....II-19
NiliMedix Seeks FDA Approval.....II-19
NiliMedix Attains CE Approval.....II-19
NationsHealth Pockets Diabetes Care & Education.....II-19
SpectRx, Inc. Divests Insulin Pump Business.....II-19
SpectRx Sells SimpleChoice Business.....II-19
Medtronic Obtains FDA Clearance for MiniMed Paradigm® Diabetes Device.....II-19
FDA Approves Smiths Medical’s Updated CozMore System.....II-19
1$100
   Matria Healthcare Acquires CorSolutions.....II-20
Johnson & Johnson Acquires Animas.....II-20
MiniMed Signs an Agreement with Smiths Medical.....II-20
Starbridge Collaborates with Medical House Products.....II-20
1$100
   Medtronic Extends Educational Support for Diabetes Management.....II-21
ADA Calls the Government to Rescind Cuts to Maine Care.....II-21
Insulet Partners with Solectron.....II-21
Animas’ IR 1250 Pump Gains FDA Approval.....II-21
1$100
   Nilimed Awaits Grant from Chief Scientist.....II-22
Animas Recalls Its Newly Released Insulin Pumps.....II-22
Animas Teams Up with Debiotech.....II-22
Deltec Turns Into Smiths Medical.....II-22
1$100
   Smiths’ Products Gain FDA Approval.....II-23
Cigna Detaches Dana.....II-23
Smiths Collaborates with TheraSense.....II-23
Animas’ Insulin Pumps Receive Nod from Health Canada.....II-23
Smiths Partners with Abbott.....II-23
1$100
   Cleo 90 Receives FDA Approval.....II-24
Animas’ Insulin Pumps Receives the Approval of Israeli Government.....II-24
Animas Relocates Headquarters.....II-24
FDA Bans Disetronic in the US.....II-24
Animas Expands.....II-24
Medtronic Retracts Infusion Sets.....II-24
1$100
   Animas Acquires Cygnus.....II-25
Novo Nordisk Signs an Agreement with Medtronic.....II-25
Roche Acquires Disetronic.....II-25
2$200
  6. Focus on Key Players.....II-273 $300  
   Animas Corporation (USA).....II-27
Debiotech S.A. (Switzerland).....II-27
Disetronic Medical Systems AG (Switzerland).....II-27
Insulet Corporation (USA).....II-27
1$100
   Matria Healthcare, Inc. (USA).....II-28
Medtronic Diabetes (USA).....II-28
Nilimedix Ltd (Israel).....II-28
Nipro Diabetes Systems (USA).....II-28
1$100
   Smiths Medical MD, Inc. (USA).....II-29
Sooil Development Co. Ltd. (Korea).....II-29
Starbridge Systems Ltd. (UK).....II-29
1$100
  7. Global Market Perspective.....II-30   
   Table 2: World Recent Past, Current & Future Market Analysis for Insulin Pumps (External) by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-301$300
   Table 3: World Long-term Projections for Insulin Pumps (External) by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-31

Table 4: World 10-Year Perspective for Insulin Pumps by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe, and Rest of World Markets for2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-31
1$300
III. MARKET36$1950
  1. The United States.....III-114 $750  
   A. Market Analysis.....III-1
Current and Future Analysis.....III-1
A Major Market for Insulin Delivery Devices.....III-1
Product Innovations/Developments.....III-1
3$225
   Strategic Corporate Developments.....III-47$525
   Key Players.....III-11
Animas Corporation.....III-11
1$75
   Becton, Dickinson & Company.....III-12
Insulet Corporation.....III-12
Matria Healthcare, Inc......III-12
Medtronic Diabetes.....III-12
1$75
   Nipro Diabetes Systems.....III-13
PolyMedica Corp.....III-13
Smiths Medical MD, Inc......III-13
B. Market Analytics.....III-13
Table 5: US Recent Past, Current & Future Market Analysis for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-13
1$150
   Table 6: US Long-term Projections for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-14
1$150
  2. Europe.....III-154 $375  
   A. Market Analysis.....III-15
Current and Future Analysis.....III-15
1$75
   B. Market Analytics.....III-16
Table 7: European Recent Past, Current & Future Market Analysis for Insulin Pumps (External) by Geographic Region – France, Germany, UK, Italy, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-16
1$150
   Table 8: European Long-term Projections for Insulin Pumps (External) by Geographic Region – France, Germany, UK, Italy, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-171$150
   Table 9: European 10-Year Perspective for Insulin Pumps by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, Spain,and Rest of Europe Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-18
1$150
  2a. France.....III-192 $175  
   Market Analysis.....III-19
Table 10: French Recent Past, Current & Future Market Analysis for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-19
1$150
   Table 11: French Long-term Projections for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-20
1$150
  2b. Germany.....III-212 $175  
   A. Market Analysis.....III-21
Current and Future Analysis.....III-21
Product Launch.....III-21
B. Market Analytics.....III-21
Table 12: German Recent Past, Current & Future Market Analysis for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-21
1$150
   Table 13: German Long-term Projections for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-22
1$150
  2c. The United Kingdom.....III-233 $225  
   A. Market Analysis.....III-23
Current and Future Analysis.....III-23
INPUT (The Insulin Pump Therapy Group).....III-23
NICE (National Institute of Clinical Excellence).....III-23
1$75
   Strategic Corporate Developments.....III-24
Starbridge Systems Ltd. – A Key Player.....III-24
1$75
   B. Market Analytics.....III-25
Table 14: United Kingdom Recent Past, Current & Future Market Analysis for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-25

Table 15: United Kingdom Long-term Projections for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-25
1$150
  2d. Italy.....III-262 $175  
   Market Analysis.....III-26
Table 16: Italian Recent Past, Current & Future Market Analysis for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-26
1$150
   Table 17: Italian Long-term Projections for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-27
1$150
  2e. Spain.....III-282 $175  
   Market Analysis.....III-28
Table 18: Spanish Recent Past, Current & Future Market Analysis for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-28
1$150
   Table 19: Spanish Long-term Projections for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-29
1$150
  2f. Rest of Europe.....III-304 $300  
   A. Market Analysis.....III-30
Current and Future Analysis.....III-30
Product Innovations/Developments.....III-30
1$75
   Strategic Corporate Developments.....III-31
Key Players.....III-31
1$75
   Debiotech S.A. (Switzerland).....III-32
Disetronic Medical Systems AG (Switzerland).....III-32
B. Market Analytics.....III-32
Table 20: Rest of Europe Recent Past, Current & Future Market Analysis for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-32
1$150
   Table 21: Rest of Europe Long-term Projections for Insulin Pumps (External) – Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-33
1$150
  3. Rest of World.....III-343 $300  
   A. Market Analysis.....III-34
Current and Future Analysis.....III-34
Review of Select Countries/Regions.....III-34
Canada.....III-34
Asia-Pacific.....III-34
Product Launches.....III-34
Strategic Corporate Developments.....III-34
1$75
   Key Players.....III-35
Nilimedix Ltd (Israel).....III-35
Sooil Development Co. Ltd. (Korea).....III-35
1$75
   B. Market Analytics.....III-36
Table 22: Rest of World Recent Past, Current & Future Market Analysis for Insulin Pumps by Product – External Insulin Pumps Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-36

Table 23: Rest of World Long-term Projections for Insulin Pumps by Product – External Insulin Pumps Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-36
1$150
IV. COMPETITIVE LANDSCAPE 48$995
  
Total Companies Profiled : 18 (including Divisions/Subsidiaries - 21)

Region/Country                 Players


The United States                  11
Japan                               1
Europe                              
     France			    
     Germany                        
     The United Kingdom             1
     Italy		            
     Spain		            
     Rest of Europe                 3
Asia-Pacific (Excluding Japan)      4
Latin America		            
Middle East                         1
Click here to request a full table of contents and more details on this project.		  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2010, Global Industry Analysts, Inc., USA.